Douglas McGraw, DO
Ophthalmology · Marysville, CANPI 1033430293
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sight Sciences, Inc. accounts for 62.2% of it on its own, with 13 other manufacturers making up the rest. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $114.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sight Sciences, Inc.$14K
- Alcon$4K
- Ivantis, Inc$1K
- Biotissue Holdings Inc.$856
- Alcon Research LLC$696
- NEW World Medical,inc.$444
- plus $1K from 8 others
Across 4 payments — averaging $48,127 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$190K
- Sight Sciences, Inc.$3K
What the payments were for
- Consulting fees$1,0004%
- Speaking & faculty fees$11,17049%
- Travel & lodging$1,4446%
- Food & beverage$9,32841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sight Sciences, Inc. | 78 | $14,267 |
| Alcon | 50 | $4,216 |
| Ivantis, Inc | 9 | $1,242 |
| Biotissue Holdings Inc. | 20 | $856 |
| Alcon Research LLC | 1 | $696 |
| NEW World Medical,inc. | 5 | $444 |
| AbbVie | 13 | $383 |
| Glaukos Corporation | 5 | $292 |
| Rxsight Inc | 2 | $205 |
| Boston Scientific | 12 | $163 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $93 |
| Carl Zeiss Meditec USA, Inc. | 1 | $48 |
| Tarsus Pharmaceuticals, Inc. | 1 | $24 |
| Dompe US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$12,658
- SION SURGICAL INSTRUMENT$3,921
- Hydrus Microstent$1,682
- Clareon$495
- Kahook Dual Blade$430
- Clearpath$430
- Ahmed Glaucoma Valve$430
- Streamline$430
- Prokera$257
- AmnioGraft$257
- Via360$252
- Wavelight Refractive Suite$143
- AcrySof IQ VIVITY$141
- Verion$132
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$122
- XEN GLAUCOMA TREATMENT SYSTEM$105
How this compares
$22,942 in reported general payments places this provider in the 90th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 692 | $19,373 |
| Ofloxacin | 1,327 | $16,665 |
| Diclofenac Sodium | 610 | $6,052 |
| Prednisolone Acetate | 120 | $4,921 |
| Brimonidine Tartrate | 56 | $1,421 |
| Latanoprost | 163 | $1,112 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 74 | $1,073 |
| Azelastine Hcl | 27 | $603 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 50 | $358 |
| MoxifloxacinMoxifloxacin Hcl | 12 | $222 |
| Tobramycin | 20 | $87 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Marysville
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.